HPV vaccine will cut cervical cancer cases by two thirds
The introduction of the HPV vaccine will slash cases of cervical cancer in women under 30 by 63 per cent by 2025, a cancer research study has predicted.
Get unlimited access
As a subscriber you will benefit from:
- Full online and mobile access to news and opinion stories
- Customised email alerts straight to your inbox (30+ alerts available)
- 4,500 practice articles in our archive
- Over £500 worth of CPD learning units